McKesson stock falls 1.19 percent as targets split

Published on 09/29/2026 at 07:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

McKesson stock posted fiscal 2027 adjusted EPS of USD 9.93 in Q1, up 20 percent year over year. Fiscal-year guidance now stands at USD 44.20-45.00, while the average analyst target is USD 973.44.

Mitarbeiter sortieren unbeschriftete Pakete in einem großen Pharma-Logistiklager mit Regalen — Fotorealistisches Bild zeigt McKesson Corporation ISIN US58155Q1031 als Pharmagroßhändler in modernem Distributionslager mit vielen Mitarbeitern, Illustration mit AI erstellt.

McKesson (ISIN US58155Q1031) was last at USD 856.29 on the NYSE on September 28, 2026, down 1.19 percent from the prior close of USD 866.64. The central investor question is whether fiscal 2027 earnings growth can close the gap between the share price and a wide range of analyst targets.

Guidance moved above the prior range

According to Zacks, McKesson generated USD 105.38 billion of revenue in fiscal 2027 first quarter, up 8 percent year over year, while adjusted EPS rose 20 percent to USD 9.93. The same quarter also produced GAAP EPS of USD 5.15, down 18 percent from USD 6.25 in the comparable period.

The earnings mix matters because the adjusted result exceeded the Zacks consensus estimate of USD 9.44 by 5.2 percent, while revenue exceeded the USD 104.39 billion consensus by 1 percent. Fiscal 2027 adjusted EPS guidance increased to USD 44.20-45.00 from USD 43.80-44.60, a USD 0.40 improvement in the range midpoint.

Analyst targets leave room for debate

MarketBeat lists a Moderate Buy consensus based on 18 analysts, including 14 Buy ratings and 4 Holds, with an average 12-month target of USD 973.44. That target is materially above the September 28 price, but the range also includes a USD 845.00 target from Royal Bank of Canada.

RBC reiterated its Sector Perform rating on September 14, 2026, according to MarketBeat. The split between a USD 845.00 downside target and the USD 973.44 average shows that earnings execution and the specialty-care outlook remain central to the valuation debate.

November 4 sets the next checkpoint

McKesson will release fiscal 2027 second-quarter results after the market close on November 4, 2026, with its investor call scheduled for 4:30 p.m. ET, according to Business Wire. That report will test whether the higher guidance range is supported by revenue growth and adjusted profitability in the first half of the fiscal year.

McKesson stock stays below yearly high

McKesson stock was last at USD 856.29 on September 28, 2026, with a session range of USD 855.65 to USD 871.20 and a 52-week range of USD 723.68 to USD 999.00. The reference price stood 14.29 percent below the 52-week high, while market capitalization was USD 100.3 billion and volume reached 549,999 shares.